产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 | |||
| 250mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 | |||
| 250mg | 95% | 询价 |
CAS No. |
746667-48-1 |
|---|---|
中文名称 |
6-(3-(6-甲基吡啶-2-基)-1H-吡唑-4-基)喹喔啉 |
英文名称 |
6-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)quinoxaline |
别名 |
HY-118810 | BIO-013077-01 | CS-0068581 | SCHEMBL4008166 | BCP30129 | MS-24106 | AKOS016013184 | 6-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)quinoxaline | 6-[3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]quinoxaline | ZB0034 | EX-A3237 | AJ-97166;AJ97166;AJ 971 |
标准英文名 |
6-(5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)quinoxaline |
分子式 |
C17H13N5 |
分子量 |
287.33 |
精确分子量 |
287.12 |
SMILES |
CC1=CC=CC(C2=NNC=C2C3=CC=C4N=CC=NC4=C3)=N1 |
标准SMILES |
CC1=CC=CC(=N1)C1=NNC=C1C1C=C2N=CC=NC2=CC=1 |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
VXJLYXCHOKEODY-UHFFFAOYSA-N |
危险类别(旧) |
H302 |
存储要求 |
Keep in dark place, Inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral(Category 4) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|